IBS
Clinical trials for IBS explained in plain language.
Never miss a new study
Get alerted when new IBS trials appear
Sign up with your email to follow new studies for IBS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a tailored mediterranean diet and exercise reverse fatty liver?
Disease control CompletedThis study tested two versions of a low-calorie Mediterranean diet, each with different carb and fat levels, combined with moderate aerobic exercise in 36 adults with obesity and fatty liver disease (NAFLD). The goal was to see if one diet plan worked better than the other at red…
Matched conditions: IBS
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Tomato diet shows promise for fatty liver and gut health
Disease control CompletedThis study looked at whether adding tomatoes to the diet can improve liver health, gut function, and blood sugar in people with non-alcoholic fatty liver disease (NAFLD). 80 adults with NAFLD and a BMI of 30 or less followed a tomato-enriched diet for 6 weeks. Researchers measure…
Matched conditions: IBS
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
Low FODMAP diet shows promise for kids with IBS
Symptom relief CompletedThis study tested a low FODMAP diet in 70 children with irritable bowel syndrome (IBS). The diet limits certain carbs that can cause gas and pain. Researchers measured symptoms like belly pain and bloating, and also looked at gut bacteria and waste products. The goal was to see i…
Matched conditions: IBS
Phase: NA • Sponsor: University of Bari • Aim: Symptom relief
Last updated Jun 17, 2026 03:27 UTC
-
New study digs into how IBS drug changes gut bugs
Knowledge-focused CompletedThis study looked at how tenapanor, a drug for irritable bowel syndrome with constipation (IBS-C), changes the bacteria and chemicals in the gut. 36 adults with IBS-C took tenapanor twice a day for 8 weeks and provided stool samples. The goal was to better understand how the drug…
Matched conditions: IBS
Phase: PHASE4 • Sponsor: Kyle Staller, MD, MPH • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC